PULMOSPHERE owner Contact Information online
from Novartis AG
PULMOSPHERE
US serial number:85125966
Application filling date:Sep. 09, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Aug. 13, 2014
Publication date:Feb. 22, 2011
Abandoned date:Jul. 16, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of disorders of the respiratory system
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
First Use: Apr. 30, 2013
Use in Commerce: Apr. 30
Services:Pharmaceutical preparations for the treatment of disorders of the respiratory system
Current owner owner name:Novartis AG
Current owner owner address:CH 4002
Basel
SWITZERLAND
Current owner legal entity type:CORPORATION
Current owner state or country:SWITZERLAND
Attorney name:Maury M Tepper III
Attorney email:mtepper@teiplaw.com
Attorney email authorized:Yes
Correspondent name address:MAURY M TEPPER III
TEPPER & EYSTER PLLC
3724 BENSON DR
RALEIGH,
NORTH CAROLINA
UNITED STATES
27609-7321
Correspondent phone:919-861-8903
Correspondent email:mtepper@teiplaw.com
Correspondent fax:919-861-8913
Correspondent email authorized:Yes
Domestic representative name:Novartis Pharmaeuticals Corporation
Domestic representative phone:919-861-8903
Domestic representative fax:919-861-8913
Trademark staff tm attorney:ELTON, DAVID JONATHAN
Trademark staff law office assigned PULMOSPHERE:LAW OFFICE 106
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (150) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) SANOFI (47) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Feb. 22, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Oct. 05, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011
